Skip to content

A Prospective, Mono-center, Interventional Study Evaluating the Effect of One Year Initial Care by Hygieno-dietary Advices With or Without Phlebotomy on Glycemia After at Least 5 Years in Patients With Dysmetabolic Iron Overload Syndrome

A Prospective, Mono-center, Interventional Study Evaluating the Effect of One Year Initial Care by Hygieno-dietary Advices With or Without Phlebotomy on Glycemia After at Least 5 Years in Patients With Dysmetabolic Iron Overload Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03942432
Acronym
EvoHSD
Enrollment
75
Registered
2019-05-08
Start date
2019-06-11
Completion date
2020-12-04
Last updated
2020-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmetabolic Iron Overload Syndrome

Brief summary

A prospective, mono-center, interventional study evaluating the effect of one year initial care by hygieno-dietary advices with or without Phlebotomy on glycemia after at least 5 years in Patients with dysmetabolic iron overload syndrome

Detailed description

Dysmetabolic iron overload syndrome (DIOS) is defined by a slight iron overload associated to features of the metabolic syndrome. This is a frequent condition that parallels the increasing prevalence of non alcoholic steato hepatitis. The role of iron overload on insulin sensitivity is described in large cohorts study, with an increased risk of type 2 diabetes in patients with increased serum ferritin, and in vitro where iron load alters key regulators of lipid and glucose metabolism. In patient with DIOS, improving diet and lifestyle is a major goal, albeit it does not allow to lower body iron stores. Therefore the role of bloodletting in this setting was raised. Several low quality studies suggested a beneficial effect of bloodletting on insulin resistance. Our group demonstrated in a large multicenter randomized trial, the lack of beneficial effect of bloodletting over one year. Because this may be a too short period of time to demonstrate a positive effect we would like to assess the long term effect of iron depletion on insulin resistance and its clinical consequence.

Interventions

OTHEROral Glucose Tolerance Test (OGTT)

Blood samples at T0, T30min, T120min

weight, length, waist measurement, cardiac frequency, blood pressure

BIOLOGICALBlood sample

Iron and cardiac markers Serum iron, serum transferrin, transferrin saturation, serum ferritin, AST, ALT, GGT, ALP, PT, Cell Blood Count, ceruloplasminemia , hyaluronic acid, cholesterolemia, HDL, LDL, triglyceridemia, hba1c

DEVICEMRI

3 Tesla abdominal MRI

Measurement of body composition

BEHAVIORALQuestionnaires

Quality of life, physical activity, alcohol consumption and eating habits

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Persons who participated in the Phlebotomy protocol: A Prospective, Randomized Study Comparing Effect of Phlebotomy and Hygieno-dietary Advices With Hygieno-dietary Advices Only on Glycemia in Patients With Dysmetabolic Iron Overload Syndrome * Persons affiliated to French Social Security * Persons who received an oral and written information on the protocol and signed the informed consent form

Exclusion criteria

* Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship) since their enrolment in the Phlebotomy protocol * Persons deprived of liberty * Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frameDescription
Dosage of fasting blood glycemia after 5 yearsYear 5Oral Glucose Tolerance Test (OGTT)

Secondary

MeasureTime frameDescription
Dosage of iron hepatic concentration after 5 yearsYear 5Blood sample
Dosage of insulin after 5 yearsYear 5Blood sample
Measurement of body compositionYear 5Bioimpedance
Measurement of insulin resistance markersYear 5Oral Glucose Tolerance Test (OGTT)
Measurement of hepatic steatosis after 5 yearsYear 5Abdominal MRI
Dosage of iron hepatic concentration proved by MRI after 5 yearsYear 5Abdominal MRI
Calculation of Framingham scoreYear 5Appreciation of cardiovascular event after 10 years based on blood pressure, cholesterol level and HDL, smoking or not, age and gender
Evaluation of quality of life after 5 yearsYear 5SF-36 questionnaire
Evaluation of physical activity after 5 yearsYear 5Baecke physical activity questionnaire : scores for physical exercise in leisure, leisure and locomotion activities
Evaluation of eating habits after 5 yearsYear 5Eating habits questionnaire
Evaluation of alcohol consumption after 5 yearsYear 5Alcohol consumption questionnaire : number of units of alcohol consumed per day
Evaluation of cardiovascular morbi-mortality after 5 yearsYear 5Mixed score based on the following events: angina pectoris, cardiac arrest, stoke

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026